Home » Topics » Disease categories and therapies » Infection

Infection
RSS

InterMune Pharmaceuticals commences Actimmune trial in MDR-TB

Aug. 7, 2000

NIH awards phase I SBIR grant to Avanir for combination herpes therapy

Aug. 7, 2000

Siga awarded two SBIR grants to support antibiotic development

Aug. 4, 2000

New polypeptides useful for Chlamydia infection

Aug. 3, 2000

Antibacterial agents under development at British Biotech

Aug. 3, 2000

Bayer's Cipro recommended for approval in treating anthrax exposure

Aug. 3, 2000

Roche seeks approval of Tamiflu in Japan

Aug. 3, 2000

Antifungal and antiparasitic cyclic peptides described by Lilly

July 31, 2000

Antiviral hexapeptides in fungus discovered at University of California

July 31, 2000

Funds will be used by ZymeTx to advance development of therapeutics and diagnostics

July 31, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...